Nothing said here yet.
to join the conversation.
Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.
MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2.
In October 2026, Inspire Medical Systems announced that the AMA CPT Editorial Panel approved new Category I CPT codes that specifically cover the Inspire V system, with these codes scheduled to take effect on January 1, 2028 and to guide future Medicare…
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Inspire Medical Systems (NYSE:INSP) and its peers.
INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
Inspire Medical Systems (NYSE:INSP) demonstrates strong core gross economics with a 85.5% gross margin, $415.2 million in cash and investments, and a raised 2026 revenue guidance range of $835 million to $875 million.
Inspire Medical Systems has seen its share price fall sharply over several years, and that slide raises a pointed question about whether the current market value still lines up with the cash the business is expected to generate.
Inspire Medical Systems (INSP) has been drawing attention after a sharp move in its share price, with the stock last closing at US$70. That shift is prompting fresh questions about how investors are treating this sleep apnea specialist.
Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
Inspire Medical Systems has seen its share price move sharply over several timeframes, which naturally puts the focus on whether the current valuation is supported by the cash it can generate.
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 7.4% in the morning session after Stifel analyst Jonathan Block raised the price target on the company to $80.00 from $75.00 while maintaining a Buy rating.